๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines

โœ Scribed by Harstrick, A.; Schmoll, H.-J.; Poliwoda, H.; Sass, G.; Rustum, Y.

Book ID
123442156
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
297 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Metallothionein-mediated cisplatin resis
Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells
โœ Paul A. Andrews; Michael P. Murphy; Stephen B. Howell ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 638 KB

We have determined the ability of two human ovarian carcinoma cells to over-express metallothioneins (MTs) and the subsequent effect this elevation has on DDP cytotoxicity. Cells of 2008 and COLO 316 human ovarian carcinomas that were resistant to CdCl2 were obtained by stepwise selection and chroni

Mechanism of resistance to cisplatin in
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53
โœ Faina Vikhanskaya; Luana Clerico; Monica Valenti; Maria S. Stanzione; Massimo Br ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 99 KB ๐Ÿ‘ 2 views

A possible novel mechanism of cross-resistance to cisplatin (CDDP) in the doxorubicin-resistant ovarian-cancer cell line A2780-DX3, which displays atypical multidrug resistance, is presented. A2780-DX3 is found to be more resistant than the parental line A2780 in terms of CDDP-induced cytotoxicity a